Adcytherix

About Adcytherix

Adcytherix develops novel antibody-drug conjugates specifically designed to target and treat various forms of cancer, addressing the significant unmet medical needs in oncology. By enhancing the precision of drug delivery, the company aims to improve patient outcomes and treatment efficacy in challenging cancer cases.

What does Adcytherix do?

Adcytherix develops novel antibody-drug conjugates specifically designed to target and treat various forms of cancer, addressing the significant unmet medical needs in oncology. By enhancing the precision of drug delivery, the company aims to improve patient outcomes and treatment efficacy in challenging cancer cases.

Where is Adcytherix located?

Adcytherix is based in Amsterdam, The Netherlands.

When was Adcytherix founded?

Adcytherix was founded in 2023.

How much funding has Adcytherix raised?

Adcytherix has raised 32530000.

Location
Amsterdam, The Netherlands
Founded
2023
Funding
32530000
Employees
8 employees
Major Investors
Pontifax
Looking for specific startups?
Try our free semantic startup search

Adcytherix

Score: 100/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Adcytherix develops novel antibody-drug conjugates specifically designed to target and treat various forms of cancer, addressing the significant unmet medical needs in oncology. By enhancing the precision of drug delivery, the company aims to improve patient outcomes and treatment efficacy in challenging cancer cases.

adcytherix.com300+
cb
Crunchbase
Founded 2023 – Amsterdam, The Netherlands

Funding

$

Estimated Funding

$32.5M+

Major Investors

Pontifax

Team (5+)

Zeina El Ali

Pharmaco-Toxicology and Safety Manager/Preclinical Research Scientist/DART Scientist/Safety Assessor/Toxicology Study Director/Clinical & Hospital…